Archives
-
Phosphatase Inhibitor Cocktail (2 Tubes, 100X)
2026-09-09
Phosphatase Inhibitor Cocktail (SKU K1015) helps limit post-lysis dephosphorylation during protein extraction and downstream phosphorylation assays. It is intended for research workflows such as immunoblotting, immunoprecipitation, kinase activity assays, and mass spectrometry, not diagnostic or medical use.
-
Trichostatin A (TSA): Practical Cell Assay Guide
2026-09-09
Trichostatin A (TSA) provides a reversible HDAC-inhibition tool for studying histone acetylation, cell-cycle responses, differentiation, and cancer-cell phenotypes. It is intended for controlled in vitro and preclinical research workflows, not clinical treatment or direct potency comparisons across cell models without assay-specific optimization.
-
Thiothixene for Macrophage Efferocytosis Research
2026-09-08
Thiothixene is a typical antipsychotic agent that can serve as a practical bridge between dopamine signaling pathway modulation and macrophage clearance biology. This guide translates its reported 2 μM in vitro use into assay design, controls, troubleshooting, and appropriately bounded connections to emerging schizophrenia treatment research.
-
Nuclear mTORC1: TerminaTOR Maps Transcriptional Control
2026-09-08
Zhong and colleagues developed TerminaTOR, a genetically encodable inhibitor that selectively perturbs mTORC1 at defined subcellular locations. Their results distinguish lysosomal mTORC1 functions in autophagy from nuclear mTORC1 control of CCAAT motif-containing gene transcription, providing a framework for studying spatially compartmentalized signaling.
-
Dihydrotestosterone (DHT): Assay Design Guide
2026-09-07
This scenario-based guide explains how Dihydrotestosterone (DHT), SKU B8214, can support reproducible androgen receptor, viability, proliferation, and signaling experiments. It covers solvent compatibility, dose selection, pathway-aware interpretation, cross-model limitations, and practical supplier evaluation.
-
(-)-JQ1 in BET Control and AML Assay Design
2026-09-07
Discover how (-)-JQ1, the inactive JQ1 stereoisomer, strengthens BET inhibitor controls and clarifies transcriptional experiments inspired by the N-MYC/eIF4G1 axis in inv(16) AML.
-
ISRIB (trans-isomer): Memory Retention & ISR
2026-09-05
ISRIB (trans-isomer) is a brain-penetrant integrated stress response inhibitor with unusual value for separating memory retention from retrieval. This article translates recent epilepsy-associated forgetting research into practical assay logic for ER stress research, molecular validation, and cognitive models.
-
PD98059: Reading ERK Causality in Cell Injury
2026-09-04
PD98059 is a reversible MEK inhibitor that helps researchers distinguish ERK-dependent signaling from downstream oxidative and mitochondrial injury. This mechanistic guide uses hepatotoxicity research to refine assay design beyond standard proliferation and apoptosis workflows.
-
Red Blood Cell Lysis Buffer for Bone Research
2026-09-04
Turn crowded mammalian blood and tissue suspensions into cleaner, more reproducible inputs for flow cytometry, nucleic acid, protein, and cell-culture workflows. This guide shows how selective erythrocyte removal can support bone and immunology studies while preserving nucleated-cell quality.
-
Ampicillin sodium: Assay Workflows & Troubleshooting
2026-09-03
Build more reproducible antibacterial activity assays with a defined β-lactam mechanism, controlled dilution design, and stability-aware handling. This guide also shows how resistant-strain comparisons and recombinant selection workflows can extend the value of Ampicillin sodium beyond a single MIC endpoint.
-
TBK1, Microglia Pyroptosis, and Painful Diabetic Neuropathy
2026-09-03
Liao et al. identify TANK-binding kinase 1 (TBK1) as an upstream driver of painful diabetic neuropathy through activation of NF-κB, the NLRP3 inflammasome, and microglial pyroptosis. The study combines genetic, pharmacological, behavioral, vascular, and tissue-level analyses to support TBK1 inhibition as a mechanistically informed strategy for reducing diabetic pain and peripheral nerve injury.
-
Cannabidiol, Endocannabinoids, and Orofacial Pain
2026-09-02
This mouse study shows that cannabidiol reduces both inflammatory orofacial nociception and pain-associated affective and cognitive deficits through coordinated peripheral and central mechanisms. Its combination of behavioral profiling, molecular assays, and fiber photometry links FAAH–anandamide signaling with CB2-, CB1-, and serotonergic pathways, while also highlighting important limits for translation to human pain treatment.
-
MG-132 for Reliable Cell Viability Assays
2026-09-02
MG-132 (Z-LLL-al, SKU A2585) provides a practical, mechanism-based way to connect proteasome inhibition with apoptosis, cell-cycle arrest, and oxidative stress measurements. This scenario-driven guide explains dose selection, solvent handling, interpretation of viability data, and criteria for choosing a dependable research reagent.
-
CHIR-99021 (CT99021) for Stem Cell Workflows
2026-09-01
CHIR-99021 (CT99021) gives researchers a selective way to tune GSK-3α/β, stabilize β-catenin, and separate pathway timing from cell-fate outcomes. This guide translates that mechanism into practical stem cell, organoid, cardiac, neuronal, and thymocyte workflows, with assay controls designed around the reference study’s unexpected β-catenin turnover pathway.
-
Nile Red for Lipid Droplet Workflows
2026-09-01
Nile Red, or Nile blue oxazone, converts lipid storage into a practical two-channel imaging readout. This guide connects intracellular lipid droplet staining with oleic-acid lipid models, autophagy studies, quantitative analysis, and troubleshooting decisions.